Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2000 participants
OBSERVATIONAL
2013-03-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Disease Undergoing PCI
NCT03911895
Optimal Stent Deployment Strategy of Contemporary Stents
NCT05292651
Antiplatelet Therapy Following Stent Implantation
NCT02051361
Prospective Assessment of Efficacy and Safety of Drug Eluting Stents
NCT02313038
Economic Evaluation German Drug-Eluting Stent Registry
NCT00866398
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Patients will be treated according to the treating cardiologists' discretion. No randomization of any medication or stent.
3. Baseline data on admission will be collected (cardiovascular risk factors, blood lipids, ect).
4. PCI procedure details and complications will be documented during the index admission.
5. Outcome events (death, MI, revascularization, stent thrombosis) will be evaluated at 1, 6, and 12 months by clinic visits or phone calls.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCI patients
Patients undergoing PCI for elective or ACS will be enrolled.
Procedure: PCI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Procedure: PCI
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Arab nationality
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Jordan Collaborating Cardiology Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istishari Hospital
Amman, , Jordan
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
JCC group websites describes the studies done by the JCC Group
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JoPCR1-12-12-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.